Biotrial, a full-service CRO and European leader in drug evaluation and pharmacology research, appoints new Head to manage its growing data management activity.
Biotrial, a full-service CRO and European leader in drug evaluation and pharmacology research, appoints new Head to manage its growing data management activity.
Biotrial, a leading CRO for early phase clinical trials, today announced that Monique Duguépéroux-Klocke has joined the company as its new Head of Data Management.
Rennes, France - November 15th, 2008
Since 1989 Biotrial has provided consistent and reliable clinical data management for in-house clinical trials, as well as complex global clinical studies. From CRF design, data entry, database design, data validation, statistics and consulting, to name a few, Biotrial’s experience includes a wide range of therapeutic areas.
Monique Duguépéroux-Klocke brings over 15 years of experience in the field of clinical research. After leaving a well-known CRO (PAREXEL in Berlin) she worked for over 10 years at one of the top French pharmaceutical companies: Servier Laboratories, as head of the Data Management, Outsourcing Department.
“We are really excited about these new changes in Biotrial’s Data Management department,” said Isabelle Cimarosti, Director of Biometrics Department. “Monique Duguépéroux-Klocke’s arrival attests to our growth and reinforces our position as a global service provider.”
Her responsibilities at Biotrial include overseeing the department’s activity and monitoring its constant growth with thorough training, recruitment and technical means. In the near future, one of her missions will be to answer client needs for data management in Phase III studies in addition to evolving Biotrial’s EDC system. Ms. Duguépéroux-Klocke holds a Master's Degree in Chemistry, and has been a member of the Data Management Biomedical Association since 1998.
Jean-Marc Gandon, Biotrial CEO, commented: “Mrs Duguépéroux-Klocke is a valuable addition to our management team. Her vast experience and her extensive background will be a great asset to the company and to our clients. With over 130 projects handled last year, the biometrics activity is in constant growth. Our team of Database Programmers and Designers, Coding Specialists, Data Entry Operators, and Data Management Project Leaders are excited about this new arrival and see it as an opportunity to continue the development of this activity within the wide range of quality clinical services offered by Biotrial.”
Philippe L'Hostis who was previously heading this department will now be heading the Biotrial ECG and Imaging Central Laboratory activities.
FDA Grants Priority Review to Merck’s sBLA for Winrevair After Early Success in ZENITH PAH Trial
July 2nd 2025Merck’s bid to update Winrevair’s label advances with FDA priority review, backed by Phase III ZENITH data showing a 76% reduction in major morbidity and mortality events in patients with pulmonary arterial hypertension.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Phase III PROMINENT Trial Initiated to Evaluate Felzartamab for Primary Membranous Nephropathy
June 30th 2025The global Phase III PROMINENT trial has begun dosing patients to evaluate felzartamab in treating primary membranous nephropathy, a serious autoimmune kidney disorder with no FDA-approved therapies.
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.